Cell Viability Assays Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company (BD)
- PerkinElmer Inc.
- Promega Corporation
- Biotium, Inc.
- Creative Bioarray
- Abcam Plc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cell viability assays is estimated at USD 2.9 billion.
The global cell viability assays market size was more than USD 2.68 billion in 2025 and is anticipated to grow at a CAGR of over 9.2%, reaching USD 6.46 billion revenue by 2035.
North America cell viability assays market is predicted to capture 38% share by 2035, driven by demand for cell-based therapies and R&D expansion.
Key players in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company (BD), PerkinElmer Inc., Promega Corporation, Biotium, Inc., Creative Bioarray, Abcam Plc.
